Safety and immunogenicity of 26-valent group A streptococcus vaccine in healthy adult volunteers

Shelly A. McNeil; Scott A. Halperin; Joanne M. Langley; Bruce Smith; Andrew Warren; Geoffrey P. Sharratt; Darlene M. Baxendale; Mark A. Reddish; Mary C. Hu; Steven D. Stroop; Janine Linden; Louis F. Fries; Peter E. Vink; James B. Dale

doi:10.1086/444458

Safety and immunogenicity of 26-valent group A streptococcus vaccine in healthy adult volunteers

Shelly A. McNeil, Scott A. Halperin, Joanne M. Langley, Bruce Smith, Andrew Warren, Geoffrey P. Sharratt, Darlene M. Baxendale, Mark A. Reddish, Mary C. Hu, Steven D. Stroop, Janine Linden, Louis F. Fries, Peter E. Vink, James B. Dale

Research output: Contribution to journal › Article › peer-review

275 Citations (Scopus)

Original language	English
Pages (from-to)	1114-1122
Number of pages	9
Journal	Clinical Infectious Diseases
Volume	41
Issue number	8
DOIs	https://doi.org/10.1086/444458
Publication status	Published - Oct 15 2005

ASJC Scopus Subject Areas

Microbiology (medical)
Infectious Diseases

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1086/444458

Cite this

McNeil, S. A., Halperin, S. A., Langley, J. M., Smith, B., Warren, A., Sharratt, G. P., Baxendale, D. M., Reddish, M. A., Hu, M. C., Stroop, S. D., Linden, J., Fries, L. F., Vink, P. E., & Dale, J. B. (2005). Safety and immunogenicity of 26-valent group A streptococcus vaccine in healthy adult volunteers. Clinical Infectious Diseases, 41(8), 1114-1122. https://doi.org/10.1086/444458

@article{c417c9b304b0402d93f9c3e8d6b047ca,

title = "Safety and immunogenicity of 26-valent group A streptococcus vaccine in healthy adult volunteers",

author = "McNeil, {Shelly A.} and Halperin, {Scott A.} and Langley, {Joanne M.} and Bruce Smith and Andrew Warren and Sharratt, {Geoffrey P.} and Baxendale, {Darlene M.} and Reddish, {Mark A.} and Hu, {Mary C.} and Stroop, {Steven D.} and Janine Linden and Fries, {Louis F.} and Vink, {Peter E.} and Dale, {James B.}",

note = "Funding Information: Potential conflicts of interest. S.A.M, S.A.H., J.M.L., B.S., G.P.S., A.W., and D.M.B. are clinical investigators at the Clinical Trials Research Centre at Dalhousie University and received financial support from the sponsor company, ID Biomedical, for the conduct of this trial; none of these investigators received personal compensation and none hold financial interests in the product. M.C.H., S.D.S., L.F.F., P.E.V., J.L., and M.A.R. are employed by the vaccine manufacturer and study sponsor, ID Biomedical, and own stock and/or stock options in ID Biomedical. J.B.D. is the inventor of the vaccine used in this study and receives research support from ID Biomedical; he owns stock and stock options in ID Biomedical and holds existing and pending patents related to the study product. Financial Support. ID Biomedical.",

year = "2005",

month = oct,

day = "15",

doi = "10.1086/444458",

language = "English",

volume = "41",

pages = "1114--1122",

journal = "Clinical Infectious Diseases",

issn = "1058-4838",

publisher = "Oxford University Press",

number = "8",

}

TY - JOUR

T1 - Safety and immunogenicity of 26-valent group A streptococcus vaccine in healthy adult volunteers

AU - McNeil, Shelly A.

AU - Halperin, Scott A.

AU - Langley, Joanne M.

AU - Smith, Bruce

AU - Warren, Andrew

AU - Sharratt, Geoffrey P.

AU - Baxendale, Darlene M.

AU - Reddish, Mark A.

AU - Hu, Mary C.

AU - Stroop, Steven D.

AU - Linden, Janine

AU - Fries, Louis F.

AU - Vink, Peter E.

AU - Dale, James B.

N1 - Funding Information: Potential conflicts of interest. S.A.M, S.A.H., J.M.L., B.S., G.P.S., A.W., and D.M.B. are clinical investigators at the Clinical Trials Research Centre at Dalhousie University and received financial support from the sponsor company, ID Biomedical, for the conduct of this trial; none of these investigators received personal compensation and none hold financial interests in the product. M.C.H., S.D.S., L.F.F., P.E.V., J.L., and M.A.R. are employed by the vaccine manufacturer and study sponsor, ID Biomedical, and own stock and/or stock options in ID Biomedical. J.B.D. is the inventor of the vaccine used in this study and receives research support from ID Biomedical; he owns stock and stock options in ID Biomedical and holds existing and pending patents related to the study product. Financial Support. ID Biomedical.

PY - 2005/10/15

Y1 - 2005/10/15

UR - http://www.scopus.com/inward/record.url?scp=26444487581&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=26444487581&partnerID=8YFLogxK

U2 - 10.1086/444458

DO - 10.1086/444458

M3 - Article

C2 - 16163629

AN - SCOPUS:26444487581

SN - 1058-4838

VL - 41

SP - 1114

EP - 1122

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

IS - 8

ER -

Safety and immunogenicity of 26-valent group A streptococcus vaccine in healthy adult volunteers

ASJC Scopus Subject Areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this